Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 6
2007 1
2008 4
2009 4
2010 3
2011 2
2012 7
2013 5
2014 1
2015 4
2016 3
2017 1
2018 4
2019 5
2020 2
2021 3
2022 7
2023 8
2024 3
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.
Wang X, Abraham S, McKenzie JAG, Jeffs N, Swire M, Tripathi VB, Luhmann UFO, Lange CAK, Zhai Z, Arthur HM, Bainbridge J, Moss SE, Greenwood J. Wang X, et al. Among authors: luhmann ufo. Nature. 2013 Jul 18;499(7458):306-11. doi: 10.1038/nature12345. Nature. 2013. PMID: 23868260 Free PMC article.
Heterogeneous Visual Function Deficits in Intermediate Age-Related Macular Degeneration: A MACUSTAR Report.
Dunbar HMP, Crabb DP, Behning C, Binns AM, Abdirahman A, Terheyden JH, Poor S, Finger RP, Leal S, Tufail A, Holz FG, Schmid M, Luhmann UFO; MACUSTAR Consortium. Dunbar HMP, et al. Among authors: luhmann ufo. Ophthalmol Sci. 2025 Jan 13;5(4):100708. doi: 10.1016/j.xops.2025.100708. eCollection 2025 Jul-Aug. Ophthalmol Sci. 2025. PMID: 40212936 Free PMC article.
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting-lessons from the MACUSTAR study.
Terheyden JH, Dunbar HMP, Schmitz-Valckenberg S, Behning C, Martinho C, Luhmann UFO, Saßmannshausen M, Lüning A, Miliu A, Aires ID, Basile PG, Batuca J, Schmid M, Moll KP, Zakaria N, Tufail A, Binns A, Crabb DP, Leal S, Finger RP, Holz FG; MACUSTAR consortium. Terheyden JH, et al. Among authors: luhmann ufo. Eye (Lond). 2025 Apr;39(6):1031-1039. doi: 10.1038/s41433-024-03568-2. Epub 2025 Feb 5. Eye (Lond). 2025. PMID: 39910281 Free PMC article. Review.
MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration.
Finger RP, Schmitz-Valckenberg S, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A, Sánchez CI, Margaron P, Normand G, Durbin MK, Luhmann UFO, Zamiri P, Cunha-Vaz J, Asmus F, Holz FG; on behalf of the MACUSTAR consortium. Finger RP, et al. Among authors: luhmann ufo. Ophthalmologica. 2019;241(2):61-72. doi: 10.1159/000491402. Epub 2018 Aug 28. Ophthalmologica. 2019. PMID: 30153664 Free PMC article. Review.
Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration - a MACUSTAR study report.
Terheyden JH, Pondorfer SG, Behning C, Berger M, Carlton J, Rowen D, Bouchet C, Poor S, Luhmann UFO, Leal S, Holz FG, Butt T, Brazier JE, Finger RP; MACUSTAR consortium. Terheyden JH, et al. Among authors: luhmann ufo. Br J Ophthalmol. 2023 Aug;107(8):1144-1150. doi: 10.1136/bjophthalmol-2021-320848. Epub 2022 Mar 30. Br J Ophthalmol. 2023. PMID: 35354561 Free PMC article. Clinical Trial.
69 results